Based on our earlier studies with TACE inhibitor TNF484 in neonatal rat pneumococcal meningitis [26], we first confirmed that TNF484 used at 1 mg/kg twice daily blocked TNF and MMP-9 in CSF of infected mice. This evidence concerns the gene MMP9 and pneumococcal meningitis.